Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers

Osteoarthritis and Cartilage

Volumn 18, Issue 11, 2010, Pages 1448-1453

  Pantsulaia, I ^a,b   Kalichman, L ^c   Kobyliansky, E ^d  

^a Institute of Medical Biotechnology   (Georgia)

^b TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hands; Inflammation markers; Osteoarthritis

Indexed keywords

BIOLOGICAL MARKER; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAND DISEASE; HAND RADIOGRAPHY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; SERUM;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HAND JOINTS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LINEAR MODELS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149410924     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.06.009     Document Type: Article

References (35)

1. Zhang Y., Niu J., Kelly-Hayes M., Chaisson C.E., Aliabadi P., Felson D.T. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am J Epidemiol 2002, 156:1021-1027.
2. Bonnet C.S., Walsh D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005, 44:7-16.
3. Goldring M.B., Marcu K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 2009, 11:224.
4. Goldring M.B., Otero M., Tsuchimochi K., Ijiri K., Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008, 67(Suppl 3):iii75-iii82.
5. Kobayashi M., Squires G.R., Mousa A., Tanzer M., Zukor D.J., Antoniou J., et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135.
6. Loeser R.F. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 2006, 54:1357-1360.
7. Hulejová H., Baresová V., Klézl Z., Polanská M., Adam M., Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 2007, 38:151-156.
8. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543.
9. Attur M., Al-Mussawir H.E., Patel J., Kitay A., Dave M., Palmer G., et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 2008, 181:5082-5088.
10. Fermor B., Christensen S.E., Youn I., Cernanec J.M., Davies C.M., Weinberg J.B. Oxygen, nitric oxide and articular cartilage. Eur Cell Mater 2007, 11(13):56-65.
11. Pearle A.D., Scanzello C.R., George S., Mandl L.A., DiCarlo E.F., Peterson M., et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007, 15:516-523.
12. Hussein M.R., Fathi N.A., El-Din A.M., Hassan H.I., Abdullah F., Al-Hakeem E., et al. Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res 2008, 14:321-328.
13. Benderdour M., Tardif G., Pelletier J.P., Di Battista J.A., Reboul P., Ranger P., et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J Rheumatol 2002, 29:1262-1272.
14. Boileau C., Martel-Pelletier J., Moldovan F., Jouzeau J.Y., Netter P., Manning P.T., et al. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. Arthritis Rheum 2002, 46:2637-2647.
15. Haringman J.J., Smeets T.J., Reinders-Blankert P., Tak P.P. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 2006, 65:294-300.
16. Lisignoli G., Toneguzzi S., Grassi F., Piacentini A., Tschon M., Cristino S., et al. Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and rantes production by arthritic osteoblasts. Cytokine 2002, 20:231-238.
17. Masuko-Hongo K., Sato T., Nishioka K. Chemokines differentially induce matrix metalloproteinase-3 and prostaglandin E2 in human articular chondrocytes. Clin Exp Rheumatol 2005, 23:57-62.
18. Alaaeddine N., Olee T., Hashimoto S., Creighton-Achermann L., Lotz M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 2001, 44:1633-1643.
19. Kwan Tat S., Amiable N., Pelletier J.P., Boileau C., Lajeunesse D., Duval N., et al. Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford) 2009, 48:1482-1490.
20. Tat S.K., Pelletier J.P., Velasco C.R., Padrines M., Martel-Pelletier J. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?. Keio J Med 2009, 58:29-40.
21. Pilichou A., Papassotiriou I., Michalakakou K., Fessatou S., Fandridis E., Papachristou G., et al. High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem 2008, 41:746-749.
22. Livshits G., Pantsulaia I., Trofimov S., Kobyliansky E. Genetic influences on the circulating cytokines involved in osteoclastogenesis. J Med Genet 2004, 41:e76.
23. Pantsulaia I., Trofimov S., Kobyliansky E., Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine 2002, 19:138-146.
24. Pantsulaia I., Trofimov S., Kobyliansky E., Livshits G. Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees. Cytokine 2005, 32:117-123.
25. Trofimov S., Pantsulaia I., Kobyliansky E., Livshits G. Circulating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population. Eur J Endocrinol 2004, 150:305-311.
26. Malkin I., Kalichman L., Kobyliansky E. Heritability of a skeletal biomarker of biological aging. Biogerontology 2007, 8:627-637.
27. Pavlovsky O. Methods of osseographic studies of the bone. Morpho-physiological Researches in Anthropology 1981, 44-61. MGU Publishing House, Moscow. O. Pavlovsky (Ed.).
28. Kellgren J., Lawrence J. Atlas of Standard Radiographs: the Epidemiology of Chronic Rheumatism 1963, Volume II. Blackwell Scientific Publications, Oxford.
29. Altman R.D., Gold G.E. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007, 15(Suppl A):A1-A56.
30. Fallon A., Spada C. Detection and Accommodation of Outliers in Normally Distributed Datasets 2008, http://www.cee.vt.edu/ewr/environmental/teach/smprimer/outlier/outlier.html.
31. Martel-Pelletier J., Boileau C., Pelletier J.P., Roughley P.J. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008, 22:351-384.
32. Toncheva A., Remichkova M., Ikonomova K., Dimitrova P., Ivanovska N. Inflammatory response in patients with active and inactive osteoarthritis. Rheumatol Int 2009, 29:1197-1203.
33. Vlad SC, Neogi T, Benjamin EJ, Larson M, Felson DT. Inflammatory markers and their association with osteoarthritis of the knee. In: American College of Rheumatology Annual Scientific Meeting, Boston, MA, USA. 2007.
34. Stankovic A., Slavic V., Stamenkovic B., Kamenov B., Bojanovic M., Mitrovic D.R. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratisl Lek Listy 2009, 110:641-646.
35. Dahaghin S., Bierma-Zeinstra S.M., Hazes J.M., Koes B.W. Clinical burden of radiographic hand osteoarthritis: a systematic appraisal. Arthritis Rheum 2006, 55:636-647.